GOLDMAN SACHS GROUP INC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 31 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$67,276
-51.7%
13,322
-51.9%
0.00%
Q2 2023$139,321
-73.4%
27,698
-67.5%
0.00%
Q1 2023$523,802
+184.7%
85,171
+186.3%
0.00%
Q1 2022$184,000
-28.4%
29,752
-6.3%
0.00%
Q4 2021$257,000
+51.2%
31,762
+178.7%
0.00%
Q3 2021$170,000
+78.9%
11,395
-45.4%
0.00%
Q1 2021$95,000
+126.2%
20,867
+6.5%
0.00%
Q4 2020$42,00019,6000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,499,149$18,814,0003.39%
New Leaf Venture Partners, L.L.C. 117,242$7,975,0002.05%
Worth Venture Partners, LLC 348,703$4,376,0001.63%
INSPIRION WEALTH ADVISORS, LLC 253,262$3,178,0000.78%
EAM Global Investors LLC 187,900$2,358,0000.65%
EAM Investors, LLC 279,613$3,509,0000.54%
ACT CAPITAL MANAGEMENT, LLC 45,000$565,0000.29%
Andesa Financial Management Inc. 33,310$418,0000.13%
Monashee Investment Management LLC 80,000$1,004,0000.12%
Sofinnova Investments, Inc. 142,635$1,790,0000.10%
View complete list of PDS BIOTECHNOLOGY CORP shareholders